Tags

Type your tag names separated by a space and hit enter

HPV prevalence and genotyping in the cervix of Chinese women.
Front Med China. 2010 Sep; 4(3):259-63.FM

Abstract

The role of human papillomavirus (HPV) as an etiologic factor of cervical cancer has been firmly established, and prophylactic vaccines are now available and have been approved in many countries. Vaccination implies a promising future for cervical cancer prevention especially for countries with very limited access to screening. However, the vaccines are not accessible in mainland China at the moment, and much needs to be understood about the potential benefit when HPV vaccines are applied to Chinese women, and to make the vaccines more specific to Chinese women. This article reviews advanced multi-center, hospital/population-based studies of most recent years, and aims to draw a definitive conclusion on HPV prevalence and genotyping in cervical cancer and precancerous lesions in China from the aspect of study population, geographic areas and time period.

Authors+Show Affiliations

Department of Cancer Epidemiology, Cancer Institute of Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, China.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

21191828

Citation

Wang, Shao-Ming, et al. "HPV Prevalence and Genotyping in the Cervix of Chinese Women." Frontiers of Medicine in China, vol. 4, no. 3, 2010, pp. 259-63.
Wang SM, Li J, Qiao YL. HPV prevalence and genotyping in the cervix of Chinese women. Front Med China. 2010;4(3):259-63.
Wang, S. M., Li, J., & Qiao, Y. L. (2010). HPV prevalence and genotyping in the cervix of Chinese women. Frontiers of Medicine in China, 4(3), 259-63. https://doi.org/10.1007/s11684-010-0095-5
Wang SM, Li J, Qiao YL. HPV Prevalence and Genotyping in the Cervix of Chinese Women. Front Med China. 2010;4(3):259-63. PubMed PMID: 21191828.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - HPV prevalence and genotyping in the cervix of Chinese women. AU - Wang,Shao-Ming, AU - Li,Jing, AU - Qiao,You-Lin, Y1 - 2010/09/09/ PY - 2010/05/10/received PY - 2010/05/18/accepted PY - 2010/12/31/entrez PY - 2010/12/31/pubmed PY - 2011/5/14/medline SP - 259 EP - 63 JF - Frontiers of medicine in China JO - Front Med China VL - 4 IS - 3 N2 - The role of human papillomavirus (HPV) as an etiologic factor of cervical cancer has been firmly established, and prophylactic vaccines are now available and have been approved in many countries. Vaccination implies a promising future for cervical cancer prevention especially for countries with very limited access to screening. However, the vaccines are not accessible in mainland China at the moment, and much needs to be understood about the potential benefit when HPV vaccines are applied to Chinese women, and to make the vaccines more specific to Chinese women. This article reviews advanced multi-center, hospital/population-based studies of most recent years, and aims to draw a definitive conclusion on HPV prevalence and genotyping in cervical cancer and precancerous lesions in China from the aspect of study population, geographic areas and time period. SN - 1673-7458 UR - https://www.unboundmedicine.com/medline/citation/21191828/HPV_prevalence_and_genotyping_in_the_cervix_of_Chinese_women. L2 - https://medlineplus.gov/cervicalcancer.html DB - PRIME DP - Unbound Medicine ER -